Search hospitals > Pennsylvania > York
WellSpan Health-York Hospital
Claim this profileYork, Pennsylvania 17403
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
263 reported clinical trials
17 medical researchers
Summary
WellSpan Health-York Hospital is a medical facility located in York, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. WellSpan Health-York Hospital is involved with conducting 263 clinical trials across 308 conditions. There are 17 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Chanh T. HuynhAdams Cancer Center1 year of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
37 drugs studied
Amit B. ShahWellSpan Health-York Cancer Center3 years of reported clinical research
Studies Prostate Cancer
Studies Small Cell Lung Cancer
21 reported clinical trials
63 drugs studied
Dan SotirescuEphrata Cancer Center4 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
31 drugs studied
Clinical Trials running at WellSpan Health-York Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Heart Failure
Small Cell Lung Cancer
Lung Carcinoma
Pancreatic Cancer
Recurrence
Lung Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WellSpan Health-York Hospital?
WellSpan Health-York Hospital is a medical facility located in York, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. WellSpan Health-York Hospital is involved with conducting 263 clinical trials across 308 conditions. There are 17 research doctors associated with this hospital, such as Chanh T. Huynh, Amit B. Shah, Dan Sotirescu, and Joseph Kannarkatt.